Inventor · disambiguated record
Eunhwa Ko
Also filed as: KO EUNHWA
8 granted patents·10 pending applications·47 citations·filing 2015–2023
81Inventor score
Files withDAEGU GYEONGBUK MEDICAL INNOVATION FOUND8UNIV YALE4DANA FARBER CANCER INST INC3VORONOI INC2LG CHEMICAL LTD1
Top patents by PatentIndex Score
18 records- 0195US9938264B2Proteolysis targeting chimera compounds and methods of preparing and using sameUNIV YALE·Filed 2016·Granted Apr 10, 2018·33 cites·20 claims
- 0292US10071164B2Estrogen-related receptor alpha based protac compounds and associated methods of useUNIV YALE·Filed 2015·Granted Sep 11, 2018·8 cites·9 claims
- 0387US11208412B2Pyrrolo-pyrimidine derivative compound, preparation method therefor, and pharmaceutical composition comprising same compound as effective ingredient for preventing or treating protein kinase-related diseaseDAEGU GYEONGBUK MEDICAL INNOVATION FOUND·Filed 2018·Granted Dec 28, 2021·2 cites·7 claims
- 0484US11117892B2Pyrrolo-pyridine derivative compound, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of protein kinase-related diseasesDAEGU GYEONGBUK MEDICAL INNOVATION FOUND·Filed 2018·Granted Sep 14, 2021·3 cites·9 claims
- 0581US10870647B2Imidazopyridine derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for preventing or treating cancerDAEGU GYEONGBUK MEDICAL INNOVATION FOUND·Filed 2017·Granted Dec 22, 2020·1 cites·21 claims
- 0673US2023248740A1Pharmaceutical Composition Comprising Compound Capable of Penetrating Blood-Brain Barrier as Effective Ingredient for Preventing or Treating Brain CancerDAEGU GYEONGBUK MEDICAL INNOVATION FOUND·Filed 2022·Application pending·0 cites
- 0773US2023181596A1Pharmaceutical Composition Comprising Compound Capable of Penetrating Blood-Brain Barrier as Effective Ingredient for Preventing or Treating Brain CancerDAEGU GYEONGBUK MEDICAL INNOVATION FOUND·Filed 2022·Application pending·0 cites
- 0863US2021267997A1Pharmaceutical Composition Comprising Compound Capable of Penetrating Blood-Brain Barrier as Effective Ingredient for Preventing or Treating Brain CancerDAEGU GYEONGBUK MEDICAL INNOVATION FOUND·Filed 2018·Application pending·0 cites
- 0963US2020325130A1Proteolysis Targeting Chimera Compounds and Methods of Preparing and Using SameUNIV YALE·Filed 2020·Application pending·0 cites
- 1060US2022106307A1Pyrrolo-pyridine derivative compound, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of protein kinase-related diseasesDAEGU GYEONGBUK MEDICAL INNOVATION FOUND·Filed 2021·Application pending·0 cites
- 1158US2024383923A1Heteroaryl derivative and use thereofVORONOI INC·Filed 2023·Application pending·0 cites
- 1254US2018186785A1Proteolysis Targeting Chimera Compounds and Methods of Preparing and Using SameUNIV YALE·Filed 2018·Application pending·0 cites
- 1351US2023322753A1Heteroaryl derivative, method for preparation thereof, and pharmaceutical composition comprising same as active ingredientVORONOI INC·Filed 2021·Application pending·0 cites
- 1446US2023295153A13-((8-((1h-pyrazol-4-yl)amino)imidazo[1,2-a]pyridin-3-yl)ethinyl)-n-phenylbenzamide derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of cancerDAEGU GYEONGBUK MEDICAL INNOVATION FOUND·Filed 2021·Application pending·0 cites
- 1543US12479847B2Pyrrolopyrimidine inhibitors of wild-type and mutant forms of LRRK2DANA FARBER CANCER INST INC·Filed 2020·Granted Nov 25, 2025·0 cites·11 claims
- 1643US12275731B2Azaindole inhibitors of wild-type and mutant forms of LRRK2DANA FARBER CANCER INST INC·Filed 2019·Granted Apr 15, 2025·0 cites·20 claims
- 1740US11447480B2Compound exhibiting enteropeptidase inhibitory activityLG CHEMICAL LTD·Filed 2019·Granted Sep 20, 2022·0 cites·11 claims
- 1838US2019016703A1Bifunctional compounds for her3 degradation and methods of useDANA FARBER CANCER INST INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eunhwa Ko files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →